Pharvaris N.V.
(PHVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 247,686 | 257,768 | 270,281 | 287,323 | 112,664 |
| Receivables | 828 | 746 | 859 | 653 | 651 |
| Income taxes - deferred | 204 | 138 | 124 | 125 | N/A |
| Other current assets | 1,791 | 3,992 | 5,098 | 6,034 | 2,116 |
| TOTAL | $250,508 | $262,644 | $276,361 | $294,134 | $115,431 |
| Non-Current Assets | |||||
| PPE Net | 128 | 115 | 90 | 67 | 65 |
| Other Non-Current Assets | 288 | 310 | 344 | 0 | 0 |
| TOTAL | $416 | $425 | $435 | $67 | $65 |
| Total Assets | $250,924 | $263,069 | $276,796 | $294,201 | $115,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,947 | 4,536 | 4,028 | 5,203 | 967 |
| Accrued Expenses | 5,052 | 4,300 | 4,777 | 4,986 | 5,102 |
| TOTAL | $8,265 | $8,836 | $8,805 | $10,190 | $6,070 |
| Non-Current Liabilities | |||||
| TOTAL | $178 | $202 | $228 | $N/A | $N/A |
| Total Liabilities | $8,444 | $9,038 | $9,033 | $10,190 | $6,070 |
| Shareholders' Equity | |||||
| Common Shares | 4,707 | 4,688 | 4,790 | 4,788 | 269 |
| Retained earnings | -103,602 | -88,533 | -79,448 | -61,166 | -50,787 |
| Other shareholders' equity | 11,595 | 9,545 | 6,934 | 4,868 | 2,257 |
| TOTAL | $242,480 | $254,031 | $267,763 | $284,012 | $109,416 |
| Total Liabilities And Equity | $250,924 | $263,069 | $276,796 | $294,201 | $115,486 |